Bianchi et al
Bianchi et al. treatment is still not recommended for SMM, because several trials suggested that individuals with SMM do not benefit from early treatment. However, the Mateos et al. trial showed a survival benefit after early treatment with lenalidomide plus dexamethasone in individuals with high-risk SMM. This trial offers prompted a reevaluation of early treatment…